By Adam Cancryn
更新于38分钟前
更新于2026年2月12日，美国东部时间下午5:22
发布于2026年2月12日，美国东部时间下午4:00
联邦机构 唐纳德·特朗普 处方药 医疗保健政策
Health and Human Services Secretary Robert F. Kennedy, Jr., speaks during the Take Back Your Health Tour event on February 4, in Nashville, Tennessee.
George Walker IV/AP/File
白宫一位政府官员告诉CNN，白宫正寻求加强对美国卫生与公众服务部（HHS）关键领域的控制，计划对高层人员进行调整，以配合政府着眼于中期选举的工作。
这些举措旨在重组HHS部长小罗伯特·F·肯尼迪的高级官员团队，任命四名新的高级顾问，他们的职责是更密切地管理该部门的日常运作以及联邦政府范围内的沟通。
政府官员表示，现任医疗保险负责人、HHS高级顾问克里斯·克劳普将担任首席顾问，并成为该部门事实上的幕僚长。
医疗保险和医疗补助服务中心（CMS）副主任约翰·布鲁克斯将担任负责CMS相关事务的高级顾问。美国食品药品监督管理局（FDA）的两名高级官员格蕾丝·格雷厄姆和凯尔·迪亚曼塔斯也将在HHS担任高级顾问，负责FDA相关事务。
现任HHS幕僚长马特·巴克汉姆将转任高级顾问，政府官员补充说，这些变动是白宫官员与肯尼迪之间沟通的结果。
HHS在周四晚些时候证实了这些人事变动，表示这些新任命将有助于在新岗位上加速推进部门议程，同时他们仍保留原职。
肯尼迪在一份声明中表示：“我很自豪能够提拔经验丰富、秉持原则的领导者加入我的核心团队——这些人有勇气和经验，能帮助我们在‘让美国重获健康’的道路上走得更快、更远。”
Chris Klomp, deputy administrator of the Centers for Medicare and Medicaid, speaks in the Oval Office of the White House in Washington, DC, on November 6, 2025.
Aaron Schwartz/Bloomberg/Getty Images
白宫正准备推进中期选举相关的重大计划，这将在很大程度上依赖于推广总统唐纳德·特朗普日益视为其国内议程核心的关键医疗政策。这包括克劳普牵头谈判的“最惠国”药品定价协议，以及特朗普助手认为能吸引广泛选民的近期健康饮食推广努力。
政府官员称，特朗普政府还计划加强对更广泛医疗保健立法的游说，旨在将政府的“最惠国”协议法典化，并推进一系列旨在降低医疗成本的其他政策。这一努力需要HHS高层更多的“推动力”。
克劳普在谈判和推广特朗普视为重大成就的药品价格协议中发挥了核心作用，因其管理专长和公众沟通技巧，在HHS内部和特朗普高级助手之间备受赞誉。
这些举措也代表了白宫试图更密切地监督肯尼迪以及HHS领导层——后者有时在协调自身机构与白宫方面存在困难，这令特朗普高级官员感到沮丧，并引发了持续数天的争议。
肯尼迪去年在一系列内部冲突后，仅上任数月就解雇了他的第一任幕僚长希瑟·弗利克·梅兰森和一名高级副手汉娜·安德森。该部门去年还因突然解雇并重新聘请FDA高级官员维尼·普拉萨德博士而陷入动荡。普拉萨德此后做出了一系列有争议的药物批准决定，推翻了职业官员的意见，激怒了制药行业。
与此同时，肯尼迪继续推进美国疫苗系统的重大改革——这是这位长期质疑疫苗的人士的首要任务，此举引起了共和党人的担忧，他们担心这可能在中期选举前损害该党政治利益。
本文已更新更多报道内容。
Federal agencies Donald Trump Prescription drugs Health care policy
White House seeks to tighten control over HHS priorities with personnel shakeup
By Adam Cancryn
Updated 38 min ago
Updated Feb 12, 2026, 5:22 PM ET
PUBLISHED Feb 12, 2026, 4:00 PM ET
Federal agencies Donald Trump Prescription drugs Health care policy
Health and Human Services Secretary Robert F. Kennedy, Jr., speaks during the Take Back Your Health Tour event on February 4, in Nashville, Tennessee.
George Walker IV/AP/File
The White House is looking to exercise tighter control over key areas of the US Health and Human Services Department, planning a shakeup of top personnel as the administration looks ahead to the midterm elections, an administration official told CNN.
The moves are aimed at restructuring HHS Secretary Robert F. Kennedy Jr.’s senior-most ranks, installing four new senior counselors who will be charged with more closely managing the department’s daily operations and communications across the federal government.
Chris Klomp, the administration’s current Medicare head and senior adviser at HHS, will become chief counselor and the department’s de facto chief of staff, the administration official said.
John Brooks, the deputy administrator at the Centers for Medicare and Medicaid Services, will be a senior counselor in charge of CMS-related issues. Two senior US Food and Drug Administration officials, Grace Graham and Kyle Diamantas, will take on senior counselor roles at HHS managing FDA-related issues.
Matt Buckham, the current HHS chief of staff, will move to a senior counselor role, the administration official said, adding that the changes came out of conversations between White House officials and Kennedy.
HHS confirmed the changes later Thursday, saying the hires would help accelerate the department’s agenda in their new roles, while still retaining their previous positions.
“I am proud to elevate battle-tested, principled leaders onto my immediate team — individuals with the courage and experience to help us move faster and further as we work to Make America Health Again,” Kennedy said in a statement.
Chris Klomp, deputy administrator of the Centers for Medicare and Medicaid, speaks in the Oval Office of the White House in Washington, DC, on November 6, 2025.
Aaron Schwartz/Bloomberg/Getty Images
The White House is preparing a midterm push that will rely heavily on promoting key health policies President Donald Trump has increasingly touted as central to his domestic agenda. That includes the “most favored nation” drug pricing deals that Klomp took a lead role in negotiating and recent efforts to spotlight healthier eating that Trump aides view as appealing to a broad spectrum of voters.
Trump officials are also planning to step up their case for broader health care legislation aimed at codifying the administration’s most favored nation deals and advancing a slate of other policies aimed at lowering health care costs, the administration official said. That effort would require more muscle in HHS’ senior ranks, they added.
Klomp, who has played a central role in negotiating and promoting the drug price deals that Trump has touted as a top accomplishment, has drawn praise at HHS and among top Trump aides for his management expertise and public messaging skills.
The moves also represent an effort to keep closer tabs on Kennedy and an HHS leadership that has struggled at times to coordinate with its own agencies and the White House, frustrating senior Trump officials and generating dayslong controversies.
Kennedy last year ousted his first chief of staff, Heather Flick Melanson, and a top deputy, Hannah Anderson, after just months on the job following a series of internal clashes. The department was also roiled last year by the abrupt firing — and then rehiring — of top FDA official Dr. Vinay Prasad, who has since made a series of controversial drug approval decisions that have overruled career staff and angered the drug industry.
In the meantime, Kennedy has also pressed ahead on a major overhaul of the nation’s vaccine system — a top priority for the longtime vaccine skeptic that has raised concerns among Republicans that it could damage the party politically ahead of the midterms.
This story has been updated with additional reporting.
Federal agencies Donald Trump Prescription drugs Health care policy
发表回复